Better Cannabis Stock: Hexo (TSX:HEXO) vs. Charlotte’s Web Holdings (CNSX:CWEB)

Hexo Corp (TSX:HEXO) has made strides recently, but could this U.S.-based CBD company be a better buy?

| More on:

Choosing between the hundreds of companies looking to profit from the growing cannabis sector isn’t easy. While some might win big in the long run, many others will likely end up on the sidelines at best. Let’s turn our attention to two potential big players in the cannabis sector: Hexo (TSX:HEXO) and Charlotte’s Web Holdings (CNSX:CWEB). Which of these is the better buy?

The case for Hexo

Hexo is increasingly becoming an attractive pot stock. While the firm currently focuses on the recreational marijuana market — an overpopulated and low-margin opportunity — Hexo currently holds about 30% of the market share in the province of Quebec, thanks to a supply agreement it signed last year.

Recently, Hexo acquired Newstrike Brands, a Toronto-based cannabis company whose 1.8 million square feet of cultivation space should come in handy. This move should allow Hexo’s production capacity (at peak) to hover around 150,000 kilograms per year, which is very competitive by industry’s standard.

Further, Hexo entered into a partnership with Molson Coors Brewing last year. This venture should give birth to cannabis-infused beverages, which are set to become legal later this year. Thus, Hexo is looking for higher-margin opportunities, which will be critical if it wants to establish itself as one of the leaders in the industry.

Hexo is expecting a boost in sales and revenues thanks to its latest acquisition, which should bode well with investors, especially considering the firm’s revenues soared by more than 1,200% over the past year and a half (or so). As a result of several recent developments, Hexo’s valuation metrics look a bit more attractive.

The case for Charlotte’s Web

Charlotte’s Web may not be as popular as some of the biggest players in the pot market, but it would be a mistake to ignore this under-the-radar company. The Colorado-based firm is one of the biggest player in the U.S. hemp CBD market. As you might recall, hemp — a non-psychoactive chemical cousin of marijuana — became legal at the federal level late last year in the U.S when the Farm Bill was signed into law.

Charlotte’s Web has its footprints all over the U.S with 6,000 retail locations across the country. The firm’s production capacity is also increasing at a steady rate. In 2018, Charlotte’s Web planted 300 acres of hemp, a more than 420% increase from 2017. This led to its production increasing to 675,000 pounds (about 306,174 kilograms) in 2018, up from just 63,000 pounds (about 28,576 kilograms) in 2017. The firm plans to plant 600 acres of hemp this year.

Perhaps the most admirable aspect of Charlotte’s Web is the fact that the firm is managing to do something few others in the cannabis sector are doing: generating consistent profits. In 2018, the firm’s revenues were $69,501, up from $40,001 in 2017. Charlotte’s Web cost of sales increased to $17,010 in 2018 from $9,248.

In both years, the company recorded a net income, which totaled $11,808,000 in 2018, up 58% year over year. Charlotte’s Web currently trades at about 20 times future earnings, which is a bargain by comparison to most of its competitors.

Which is the better buy?

Neither company possesses a very strong presence outside North America. However, Charlotte’s Web is currently operating in the largest cannabis market in the world.

While the U.S. has yet to legalize recreational uses of marijuana, the hemp market is not to be ignored, and Charlotte’s Web is consistently increasing its revenues and is even profitable — a rarity in the cannabis sector at the moment.

Though Hexo is also an attractive option — thanks to its major supply agreement with Quebec and its partnership with Molson Coors — it looks to be second place to Charlotte’s Web at this point.

The Motley Fool owns shares of Molson Coors Brewing. Fool contributor Prosper Bakiny owns shares of Hexo Corp.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »